PURE Bioscience (OTCMKTS:PURE) Share Price Passes Above 200-Day Moving Average – Should You Sell?

by · The Cerbat Gem

PURE Bioscience (OTCMKTS:PURE – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.06 and traded as high as $0.08. PURE Bioscience shares last traded at $0.0723, with a volume of 35,731 shares.

PURE Bioscience Stock Up 7.9%

The company has a market cap of $9.40 million, a price-to-earnings ratio of -2.41 and a beta of 0.11. The stock’s 50-day simple moving average is $0.08 and its 200 day simple moving average is $0.06.

PURE Bioscience (OTCMKTS:PURE – Get Free Report) last announced its quarterly earnings results on Monday, March 16th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.44 million for the quarter.

About PURE Bioscience

(Get Free Report)

PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.

PURE’s product suite includes concentrate formulations and ready-to-use solutions.

Featured Stories